List of Tables
Table 1. Global Low Molecular Weight Nucleic Acid Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Low Molecular Weight Nucleic Acid Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Low Molecular Weight Nucleic Acid Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Low Molecular Weight Nucleic Acid Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Low Molecular Weight Nucleic Acid Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Low Molecular Weight Nucleic Acid Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Low Molecular Weight Nucleic Acid Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Low Molecular Weight Nucleic Acid Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Low Molecular Weight Nucleic Acid Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Low Molecular Weight Nucleic Acid Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Low Molecular Weight Nucleic Acid Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Low Molecular Weight Nucleic Acid Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low Molecular Weight Nucleic Acid Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Low Molecular Weight Nucleic Acid Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Low Molecular Weight Nucleic Acid Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Low Molecular Weight Nucleic Acid Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Low Molecular Weight Nucleic Acid Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Low Molecular Weight Nucleic Acid Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Low Molecular Weight Nucleic Acid Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Low Molecular Weight Nucleic Acid Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Low Molecular Weight Nucleic Acid Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Low Molecular Weight Nucleic Acid Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Low Molecular Weight Nucleic Acid Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Low Molecular Weight Nucleic Acid Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Low Molecular Weight Nucleic Acid Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Low Molecular Weight Nucleic Acid Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Low Molecular Weight Nucleic Acid Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Low Molecular Weight Nucleic Acid Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Low Molecular Weight Nucleic Acid Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Low Molecular Weight Nucleic Acid Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Low Molecular Weight Nucleic Acid Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Low Molecular Weight Nucleic Acid Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Low Molecular Weight Nucleic Acid Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Low Molecular Weight Nucleic Acid Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Low Molecular Weight Nucleic Acid Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Low Molecular Weight Nucleic Acid Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Low Molecular Weight Nucleic Acid Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Low Molecular Weight Nucleic Acid Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Low Molecular Weight Nucleic Acid Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Low Molecular Weight Nucleic Acid Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Low Molecular Weight Nucleic Acid Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Low Molecular Weight Nucleic Acid Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Low Molecular Weight Nucleic Acid Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Low Molecular Weight Nucleic Acid Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Low Molecular Weight Nucleic Acid Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Low Molecular Weight Nucleic Acid Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Low Molecular Weight Nucleic Acid Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Low Molecular Weight Nucleic Acid Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novartis Low Molecular Weight Nucleic Acid Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Ionis Company Information
Table 76. Ionis Description and Business Overview
Table 77. Ionis Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Ionis Low Molecular Weight Nucleic Acid Drugs Product
Table 79. Ionis Recent Developments/Updates
Table 80. Nippon Shinyaku Company Information
Table 81. Nippon Shinyaku Description and Business Overview
Table 82. Nippon Shinyaku Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Nippon Shinyaku Low Molecular Weight Nucleic Acid Drugs Product
Table 84. Nippon Shinyaku Recent Developments/Updates
Table 85. Alnylam Company Information
Table 86. Alnylam Description and Business Overview
Table 87. Alnylam Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Alnylam Low Molecular Weight Nucleic Acid Drugs Product
Table 89. Alnylam Recent Developments/Updates
Table 90. Sarepta Therapeutics Company Information
Table 91. Sarepta Therapeutics Description and Business Overview
Table 92. Sarepta Therapeutics Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sarepta Therapeutics Low Molecular Weight Nucleic Acid Drugs Product
Table 94. Sarepta Therapeutics Recent Developments/Updates
Table 95. MiNA Therapeutics Company Information
Table 96. MiNA Therapeutics Description and Business Overview
Table 97. MiNA Therapeutics Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. MiNA Therapeutics Low Molecular Weight Nucleic Acid Drugs Product
Table 99. MiNA Therapeutics Recent Developments/Updates
Table 100. BioNTech Company Information
Table 101. BioNTech Description and Business Overview
Table 102. BioNTech Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. BioNTech Low Molecular Weight Nucleic Acid Drugs Product
Table 104. BioNTech Recent Developments/Updates
Table 105. Moderna Company Information
Table 106. Moderna Description and Business Overview
Table 107. Moderna Low Molecular Weight Nucleic Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Moderna Low Molecular Weight Nucleic Acid Drugs Product
Table 109. Moderna Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Low Molecular Weight Nucleic Acid Drugs Distributors List
Table 113. Low Molecular Weight Nucleic Acid Drugs Customers List
Table 114. Low Molecular Weight Nucleic Acid Drugs Market Trends
Table 115. Low Molecular Weight Nucleic Acid Drugs Market Drivers
Table 116. Low Molecular Weight Nucleic Acid Drugs Market Challenges
Table 117. Low Molecular Weight Nucleic Acid Drugs Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Low Molecular Weight Nucleic Acid Drugs
Figure 2. Global Low Molecular Weight Nucleic Acid Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Low Molecular Weight Nucleic Acid Drugs Market Share by Type: 2024 & 2031
Figure 4. ASO Product Picture
Figure 5. siRNA Product Picture
Figure 6. Other Product Picture
Figure 7. Global Low Molecular Weight Nucleic Acid Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Low Molecular Weight Nucleic Acid Drugs Market Share by Application: 2024 & 2031
Figure 9. Cardiovascular Diseases
Figure 10. Hepatitis B
Figure 11. Hypertension
Figure 12. Other
Figure 13. Global Low Molecular Weight Nucleic Acid Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Low Molecular Weight Nucleic Acid Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Low Molecular Weight Nucleic Acid Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Low Molecular Weight Nucleic Acid Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Low Molecular Weight Nucleic Acid Drugs Report Years Considered
Figure 18. Low Molecular Weight Nucleic Acid Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Low Molecular Weight Nucleic Acid Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Low Molecular Weight Nucleic Acid Drugs Players: Market Share by Revenue in Low Molecular Weight Nucleic Acid Drugs in 2024
Figure 21. Low Molecular Weight Nucleic Acid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Low Molecular Weight Nucleic Acid Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Low Molecular Weight Nucleic Acid Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Low Molecular Weight Nucleic Acid Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Low Molecular Weight Nucleic Acid Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Low Molecular Weight Nucleic Acid Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Low Molecular Weight Nucleic Acid Drugs by Type (2020-2031)
Figure 55. Global Low Molecular Weight Nucleic Acid Drugs Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Low Molecular Weight Nucleic Acid Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Low Molecular Weight Nucleic Acid Drugs by Application (2020-2031)
Figure 58. Global Low Molecular Weight Nucleic Acid Drugs Price (US$/Unit) by Application (2020-2031)
Figure 59. Low Molecular Weight Nucleic Acid Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
